Previous close | 1.8600 |
Open | 1.8400 |
Bid | 0.0000 x 4000 |
Ask | 0.0000 x 2200 |
Day's range | 1.8400 - 2.0600 |
52-week range | 1.4200 - 10.8800 |
Volume | |
Avg. volume | 3,026,188 |
Market cap | 106.877M |
Beta (5Y monthly) | 1.19 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Key Insights Significantly high institutional ownership implies Emergent BioSolutions' stock price is sensitive to...
Net Loss Narrows in Q4; Full Year Revenues Hit Guidance Mid-Point
Emergent (EBS) reports mixed earnings for fourth-quarter 2023. The company signs a forbearance agreement with its lenders, effective till April 2023-end.